Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dongping Zhou

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
European Journal of Medicinal Chemistry|March 2, 2018
Design, synthesis, and structure-activity-relationship of a novel series of CXCR4 antagonistsZhanhui Li, Yujie Wang, Chunyan Fu, et al.
Journal of Medicinal Chemistry|August 6, 2019
Discovery of Zanubrutinib (BGB-3111), a Novel, Potent, and Selective Covalent Inhibitor of Bruton's Tyrosine KinaseYunhang Guo, Ye Liu, Nan Hu, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
European Journal of Medicinal Chemistry|March 2, 2018
Design, synthesis, and structure-activity-relationship of a novel series of CXCR4 antagonistsZhanhui Li, Yujie Wang, Chunyan Fu, et al.
Journal of Medicinal Chemistry|August 6, 2019
Discovery of Zanubrutinib (BGB-3111), a Novel, Potent, and Selective Covalent Inhibitor of Bruton's Tyrosine KinaseYunhang Guo, Ye Liu, Nan Hu, et al.
Pageof 2